LINC-ROR

Across TCGA pan-cancer cohorts, LINC-ROR RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC-ROR data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher LINC-ROR RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC-ROR expression acts as an unfavorable survival marker.

DLBC, ACC, and THCA are the cancer types where LINC-ROR RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.466	0.953	.004	63	view →
ACC	DFS	Tertile	III,IV	0.050	0.421	<.001	63	view →
THCA	DFS	Tertile	All	0.750	0.929	.006	57	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.675	<.001	54	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	42	view →
MESO	OS	Quartile	All	0.226	0.605	<.001	36	view →
STAD	DFS	Median	IV	0.196	0.672	.003	27	view →
LIHC	OS	Quartile	All	0.619	0.864	.005	26	view →
KICH	OS	Quartile	II,III,IV	0.227	0.880	.004	16	view →
LAML	DFS	Quartile	All	0.286	0.633	.001	14	view →
KIRC	DFS	Tertile	All	0.738	0.815	.040	12	view →
GBM	OS	Tertile	All	0.247	0.448	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC-ROR–DLBC (DFS)

Open the DLBC breakdown →